Recruiting
Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC
NCT05854849
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +15 more
- Locations
-
- Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China